Industry: Service & Software
Published Date: 2025-03-11
Pages: 148 Pages
Report ld: 4640968
Request Sample
Customized Report
The global market for Gene Knockout Cell Line Construction Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Gene Knockout Cell Line Construction Service refers to a specialized scientific service provided by biotechnology companies and research institutions, aimed at creating cell lines with specific genes intentionally disrupted or "knocked out." This service utilizes advanced gene editing technologies to delete or inactivate a target gene within the genome of a cell line, allowing researchers to study the gene's function, role in disease, or potential as a therapeutic target.
North American market for Gene Knockout Cell Line Construction Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Gene Knockout Cell Line Construction Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Gene Knockout Cell Line Construction Service was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Gene Knockout Cell Line Construction Service include OriGene, Creative Bioarray, Horizon Discovery, Synthego, Cyagen, Cellecta, BiologicsCorp, Kyinno Bio, Porton Advanced, Cytosurge, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Gene Knockout Cell Line Construction Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Gene Knockout Cell Line Construction Service by region & country, by Type, and by Application.
The Gene Knockout Cell Line Construction Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Knockout Cell Line Construction Service.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Gene Knockout Cell Line Construction Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Gene Knockout Cell Line Construction Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Gene Knockout Cell Line Construction Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Gene Knockout Cell Line Construction Service Product Introduction
1.2 Global Gene Knockout Cell Line Construction Service Market Size Forecast (2020-2031)
1.3 Gene Knockout Cell Line Construction Service Market Trends & Drivers
1.3.1 Gene Knockout Cell Line Construction Service Industry Trends
1.3.2 Gene Knockout Cell Line Construction Service Market Drivers & Opportunity
1.3.3 Gene Knockout Cell Line Construction Service Market Challenges
1.3.4 Gene Knockout Cell Line Construction Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Gene Knockout Cell Line Construction Service Players Revenue Ranking (2024)
2.2 Global Gene Knockout Cell Line Construction Service Revenue by Company (2020-2025)
2.3 Key Companies Gene Knockout Cell Line Construction Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Gene Knockout Cell Line Construction Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Gene Knockout Cell Line Construction Service
2.6 Gene Knockout Cell Line Construction Service Market Competitive Analysis
2.6.1 Gene Knockout Cell Line Construction Service Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Gene Knockout Cell Line Construction Service Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Knockout Cell Line Construction Service as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 CRISPR/Cas9
3.1.2 TALEN
3.1.3 Others
3.2 Global Gene Knockout Cell Line Construction Service Sales Value by Type
3.2.1 Global Gene Knockout Cell Line Construction Service Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Gene Knockout Cell Line Construction Service Sales Value, by Type (2020-2031)
3.2.3 Global Gene Knockout Cell Line Construction Service Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Academic and Research Institutions
4.1.2 Pharmaceutical and Biotechnology Companies
4.2 Global Gene Knockout Cell Line Construction Service Sales Value by Application
4.2.1 Global Gene Knockout Cell Line Construction Service Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Gene Knockout Cell Line Construction Service Sales Value, by Application (2020-2031)
4.2.3 Global Gene Knockout Cell Line Construction Service Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Gene Knockout Cell Line Construction Service Sales Value by Region
5.1.1 Global Gene Knockout Cell Line Construction Service Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Gene Knockout Cell Line Construction Service Sales Value by Region (2020-2025)
5.1.3 Global Gene Knockout Cell Line Construction Service Sales Value by Region (2026-2031)
5.1.4 Global Gene Knockout Cell Line Construction Service Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
5.2.2 North America Gene Knockout Cell Line Construction Service Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
5.3.2 Europe Gene Knockout Cell Line Construction Service Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
5.4.2 Asia Pacific Gene Knockout Cell Line Construction Service Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
5.5.2 South America Gene Knockout Cell Line Construction Service Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
5.6.2 Middle East & Africa Gene Knockout Cell Line Construction Service Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Gene Knockout Cell Line Construction Service Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
6.3 United States
6.3.1 United States Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
6.3.2 United States Gene Knockout Cell Line Construction Service Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Gene Knockout Cell Line Construction Service Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
6.4.2 Europe Gene Knockout Cell Line Construction Service Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Gene Knockout Cell Line Construction Service Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
6.5.2 China Gene Knockout Cell Line Construction Service Sales Value by Type (%), 2024 VS 2031
6.5.3 China Gene Knockout Cell Line Construction Service Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
6.6.2 Japan Gene Knockout Cell Line Construction Service Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Gene Knockout Cell Line Construction Service Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
6.7.2 South Korea Gene Knockout Cell Line Construction Service Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Gene Knockout Cell Line Construction Service Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
6.8.2 Southeast Asia Gene Knockout Cell Line Construction Service Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Gene Knockout Cell Line Construction Service Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Gene Knockout Cell Line Construction Service Sales Value, 2020-2031
6.9.2 India Gene Knockout Cell Line Construction Service Sales Value by Type (%), 2024 VS 2031
6.9.3 India Gene Knockout Cell Line Construction Service Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 OriGene
7.1.1 OriGene Profile
7.1.2 OriGene Main Business
7.1.3 OriGene Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.1.4 OriGene Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.1.5 OriGene Recent Developments
7.2 Creative Bioarray
7.2.1 Creative Bioarray Profile
7.2.2 Creative Bioarray Main Business
7.2.3 Creative Bioarray Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.2.4 Creative Bioarray Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.2.5 Creative Bioarray Recent Developments
7.3 Horizon Discovery
7.3.1 Horizon Discovery Profile
7.3.2 Horizon Discovery Main Business
7.3.3 Horizon Discovery Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.3.4 Horizon Discovery Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.3.5 Horizon Discovery Recent Developments
7.4 Synthego
7.4.1 Synthego Profile
7.4.2 Synthego Main Business
7.4.3 Synthego Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.4.4 Synthego Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.4.5 Synthego Recent Developments
7.5 Cyagen
7.5.1 Cyagen Profile
7.5.2 Cyagen Main Business
7.5.3 Cyagen Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.5.4 Cyagen Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.5.5 Cyagen Recent Developments
7.6 Cellecta
7.6.1 Cellecta Profile
7.6.2 Cellecta Main Business
7.6.3 Cellecta Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.6.4 Cellecta Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.6.5 Cellecta Recent Developments
7.7 BiologicsCorp
7.7.1 BiologicsCorp Profile
7.7.2 BiologicsCorp Main Business
7.7.3 BiologicsCorp Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.7.4 BiologicsCorp Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.7.5 BiologicsCorp Recent Developments
7.8 Kyinno Bio
7.8.1 Kyinno Bio Profile
7.8.2 Kyinno Bio Main Business
7.8.3 Kyinno Bio Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.8.4 Kyinno Bio Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.8.5 Kyinno Bio Recent Developments
7.9 Porton Advanced
7.9.1 Porton Advanced Profile
7.9.2 Porton Advanced Main Business
7.9.3 Porton Advanced Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.9.4 Porton Advanced Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.9.5 Porton Advanced Recent Developments
7.10 Cytosurge
7.10.1 Cytosurge Profile
7.10.2 Cytosurge Main Business
7.10.3 Cytosurge Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.10.4 Cytosurge Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.10.5 Cytosurge Recent Developments
7.11 AcceGen
7.11.1 AcceGen Profile
7.11.2 AcceGen Main Business
7.11.3 AcceGen Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.11.4 AcceGen Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.11.5 AcceGen Recent Developments
7.12 System Biosciences
7.12.1 System Biosciences Profile
7.12.2 System Biosciences Main Business
7.12.3 System Biosciences Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.12.4 System Biosciences Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.12.5 System Biosciences Recent Developments
7.13 Altogen Labs
7.13.1 Altogen Labs Profile
7.13.2 Altogen Labs Main Business
7.13.3 Altogen Labs Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.13.4 Altogen Labs Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.13.5 Altogen Labs Recent Developments
7.14 Syd Labs
7.14.1 Syd Labs Profile
7.14.2 Syd Labs Main Business
7.14.3 Syd Labs Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.14.4 Syd Labs Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.14.5 Syd Labs Recent Developments
7.15 Lifeasible
7.15.1 Lifeasible Profile
7.15.2 Lifeasible Main Business
7.15.3 Lifeasible Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.15.4 Lifeasible Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.15.5 Lifeasible Recent Developments
7.16 GenScript
7.16.1 GenScript Profile
7.16.2 GenScript Main Business
7.16.3 GenScript Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.16.4 GenScript Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.16.5 GenScript Recent Developments
7.17 Ubigene
7.17.1 Ubigene Profile
7.17.2 Ubigene Main Business
7.17.3 Ubigene Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.17.4 Ubigene Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.17.5 Ubigene Recent Developments
7.18 Beyotime
7.18.1 Beyotime Profile
7.18.2 Beyotime Main Business
7.18.3 Beyotime Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.18.4 Beyotime Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.18.5 Beyotime Recent Developments
7.19 Abace Biotechnology
7.19.1 Abace Biotechnology Profile
7.19.2 Abace Biotechnology Main Business
7.19.3 Abace Biotechnology Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.19.4 Abace Biotechnology Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.19.5 Abace Biotechnology Recent Developments
7.20 Viewsolid Biotechnology
7.20.1 Viewsolid Biotechnology Profile
7.20.2 Viewsolid Biotechnology Main Business
7.20.3 Viewsolid Biotechnology Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.20.4 Viewsolid Biotechnology Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.20.5 Viewsolid Biotechnology Recent Developments
7.21 iGeneBio
7.21.1 iGeneBio Profile
7.21.2 iGeneBio Main Business
7.21.3 iGeneBio Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.21.4 iGeneBio Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.21.5 iGeneBio Recent Developments
7.22 VectorBuilder
7.22.1 VectorBuilder Profile
7.22.2 VectorBuilder Main Business
7.22.3 VectorBuilder Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.22.4 VectorBuilder Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.22.5 VectorBuilder Recent Developments
7.23 BrainVTA
7.23.1 BrainVTA Profile
7.23.2 BrainVTA Main Business
7.23.3 BrainVTA Gene Knockout Cell Line Construction Service Products, Services and Solutions
7.23.4 BrainVTA Gene Knockout Cell Line Construction Service Revenue (US$ Million) & (2020-2025)
7.23.5 BrainVTA Recent Developments
8 Industry Chain Analysis
8.1 Gene Knockout Cell Line Construction Service Industrial Chain
8.2 Gene Knockout Cell Line Construction Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Gene Knockout Cell Line Construction Service Sales Model
8.5.2 Sales Channel
8.5.3 Gene Knockout Cell Line Construction Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Gene Knockout Cell Line Construction Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-27
Pages: 163
USD 4900.00
(Single User License)
The global Gene Knockout Cell Line Construction Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 112
USD 4250.00
(Single User License)
The global market for Gene Knockout Cell Line Construction Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 143
USD 3950.00
(Single User License)
The global Gene Knockout Cell Line Construction Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 149
USD 2900.00
(Single User License)
The global Gene Knockout Cell Line Construction Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 111
USD 4250.00
(Single User License)
The global Gene Knockout Cell Line Construction Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 173
USD 4900.00
(Single User License)
The global market for Gene Knockout Cell Line Construction Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 107
USD 2900.00
(Single User License)
Gene Knockout Cell Line Construction Service refers to a specialized scientific service provided by biotechnology companies and research institutions, aimed at creating cell lines with specific genes intentionally disrupted or "knocked out." This service utilizes advanced gene editing technologies to delete or inactivate a target gene within the genome of a cell line, allowing researchers to study the gene's function, role in disease, or potential as a therapeutic target.
Published Date: 2024-06-11
Pages: 102
USD 2900.00
(Single User License)
Gene Knockout Cell Line Construction Service refers to a specialized scientific service provided by biotechnology companies and research institutions, aimed at creating cell lines with specific genes intentionally disrupted or "knocked out." This service utilizes advanced gene editing technologies to delete or inactivate a target gene within the genome of a cell line, allowing researchers to study the gene's function, role in disease, or potential as a therapeutic target.
Published Date: 2024-06-11
Pages: 143
USD 4350.00
(Single User License)
Gene Knockout Cell Line Construction Service refers to a specialized scientific service provided by biotechnology companies and research institutions, aimed at creating cell lines with specific genes intentionally disrupted or "knocked out." This service utilizes advanced gene editing technologies to delete or inactivate a target gene within the genome of a cell line, allowing researchers to study the gene's function, role in disease, or potential as a therapeutic target.
Published Date: 2024-06-11
Pages: 166
USD 4900.00
(Single User License)
The global Gene Knockout Cell Line Construction Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-27
Pages: 163
The global Gene Knockout Cell Line Construction Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 112
The global market for Gene Knockout Cell Line Construction Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 143
The global Gene Knockout Cell Line Construction Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 149
The global Gene Knockout Cell Line Construction Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 111
The global Gene Knockout Cell Line Construction Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 173
The global market for Gene Knockout Cell Line Construction Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 107
Gene Knockout Cell Line Construction Service refers to a specialized scientific service provided by biotechnology companies and research institutions, aimed at creating cell lines with specific genes intentionally disrupted or "knocked out." This service utilizes advanced gene editing technologies to delete or inactivate a target gene within the genome of a cell line, allowing researchers to study the gene's function, role in disease, or potential as a therapeutic target.
Published: 2024-06-11
Pages: 102
Gene Knockout Cell Line Construction Service refers to a specialized scientific service provided by biotechnology companies and research institutions, aimed at creating cell lines with specific genes intentionally disrupted or "knocked out." This service utilizes advanced gene editing technologies to delete or inactivate a target gene within the genome of a cell line, allowing researchers to study the gene's function, role in disease, or potential as a therapeutic target.
Published: 2024-06-11
Pages: 143
Gene Knockout Cell Line Construction Service refers to a specialized scientific service provided by biotechnology companies and research institutions, aimed at creating cell lines with specific genes intentionally disrupted or "knocked out." This service utilizes advanced gene editing technologies to delete or inactivate a target gene within the genome of a cell line, allowing researchers to study the gene's function, role in disease, or potential as a therapeutic target.
Published: 2024-06-11
Pages: 166
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now